Jubilant Pharmova Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.89 per cent from ₹2,122.50 crore. This corresponds to a year-on-year *(YoY) growth of 18.73 per cent.
Operating Profit
Operating Profit stands at ₹325.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.40 per cent from ₹249.70 crore. This corresponds to a year-on-year *(YoY) decline of 4.80 per cent.
PBDT
PBDT stands at ₹292.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 36.76 per cent from ₹214.10 crore. This corresponds to a year-on-year *(YoY) decline of 2.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹176.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 88.44 per cent from ₹93.40 crore. This corresponds to a year-on-year *(YoY) decline of 14.56 per cent.
Net Profit
Net Profit stands at ₹119.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 113.80 per cent from ₹55.80 crore. This represents a 21.15 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Jubilant Pharmova Ltd News
Jubilant Pharmova Ltd Earnings
- YOY
- QOQ
Jubilant Pharmova Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Jubilant Pharmova Ltd Research Reports
Jubilant Pharmova Ltd Financial Reports
Jubilant Pharmova Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Jubilant Pharmo | -0.73% | -1.83% | -0.76% | 8.48% | -7.85% | -18.92% |
| Natco Pharma | 2.30% | 5.57% | 13.86% | -8.65% | 14.41% | 0.69% |
| Cohance Life | 2.43% | -0.35% | 5.72% | 25.88% | -1.22% | -56.18% |
| Alembic Pharma | 2.35% | 0.36% | 12.70% | 16.44% | 5.21% | -18.72% |
| Alivus Life | 1.54% | 0.88% | 10.80% | 10.85% | 30.95% | 8.06% |
| Concord Biotech | -0.76% | 1.25% | -3.97% | 24.22% | -2.87% | -29.15% |
| Corona Remedies | 0.75% | 1.71% | 17.87% | 29.28% | 45.24% | 41.76% |
Company Info
Company Information
Chairman (Non-Executive) : Shyam S Bhartia
Co-Chairman : Hari S Bhartia
Independent Director : Vivek Mehra
Independent Director : SUSHIL KUMAR ROONGTA
Managing Director : Priyavrat Bhartia
Joint Managing Director : Arjun Shanker Bhartia
Independent Director : Arun Seth
Independent Director : Shirish Gundopant Belapure
Whole-time Director : Ramakrishnan Arul
Independent Director : Harsh Mahajan
Independent Director : Shivpriya Nanda
Whole Time Director : Arvind Chokhany
Company Sec. & Compli. Officer : Naresh Kapoor.